Abstract:Objective: To evaluate the diagnosic performance of a novel Mycobacterium tuberculosis (MTB) specific T-cell based assay for tuberculosis, which targets the mRNA detection of interferon gamma-induced protein 10 (IP-10). Methods: Suspected tuberculosis patients were prospectively and consecutively recruited in Beijing Chest Hospital between March 2018 and November 2019, and individuals with lower risk of MTB infection were also recruited. IP-10.TB and T-SPOT.TB assays were simulataneously performed on peripheral blood samples. The diagnostic performance of IP-10.TB and T-SPOT.TB were analyzed using the receiver operating characteristic curve. Accordance of IP-10.TB and T-SPOT.TB was analyzed by Cohen's kappa test, while the correlation between the expression level of IP-10 mRNA in IP-10.TB test and the number of SFCs in T-SPOT.TB test were analyzed by Pearson correlation test. Results: A total of 235 patients with tuberculosis, 110 patients with other diseases and 153 individuals with lower risk of MTB infection were included in the final analysis. No significant difference was detected in the rate of indeterminate results between IP-10.TB assay (3/498, 0.60%) and T-SPOT.TB assay (6/498, 1.21%). The total sensitivity and specificity of IP-10.TB assay were 91.3% (95%CI 86.8%-94.6%) and 81.1% (95%CI 75.8%-85.7%). The specificity of IP-10.TB in individuals with lower risk of MTB infection was 98.0% (95%CI 94.4%-99.6%). The total sensitivity and specificity of T-SPOT.TB assay were 93.0% (95%CI 88.9%-96.0%) and 83.8% (95%CI 78.7%-88.1%). The specificity of T-SPOT.TB in individuals with lower risk of MTB infection was 100% (95%CI 97.6%-100.0%). No significant differences were detected in sensitivity and specificity between IP-10.TB and T-SPOT.TB assays (P>0.05). The positive coincidence rate of these 2 methods was 91.0% (95%CI 87.5%-94.5%), and the negative coincidence rate was 88.9% (95%CI 84.9%-92.9%) and the total coincidence rate was 90.0% (95%CI 87.3%-92.6%). The Cohen's kappa value was 0.80 (95%CI 0.75-0.85, P<0.001) between IP-10.TB and T-SPOT.TB assays. Conclusion: These results showed that the diagnostic performance of IP-10.TB was consistent with that in T-SPOT.TB, and this test could be a novel adjunctive tool for the diagnosis of tuberculosis.

The CFP21 Protein-Elispot Method of Diagnosing Mycobacterium Tuberculosis Infection and Its Diagnostic Value

Clinical Application and Antigenicity of ESAT-6/CFP-10 Fusion Protein in Diagnosis of Tuberculosis

Preparation of Immunochromatographic Strips for Rapid Detection of Early Secreted Protein ESAT-6 and Culture Filtrate Protein CFP-10 from Mycobacterium Tuberculosis.

Novel Monoclonal Antibodies To Esat-6 And Cfp-10 Antigens For Elisa-Based Diagnosis Of Pleural Tuberculosis

Cloning and expression of CFP10-ESAT-6-CFP21 fusion protein of Mycobacterium tuberculosis and whole blood IFN-γ assay based on the fusion protein

[The Comparison of Different Antigens in Enzyme-Linked Immunospot Assay for the Diagnosis of Tuberculosis.].

Diagnostic Value of ELISPOT by Recombinant Rv0315 Protein of Mycobacterium Tuberculosis in Detection of Active Pulmonary Tuberculosis

Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients

A preliminary evaluation of a new compound multiple antigens for detection of pulmonary tuberculosis by ELISPOT

[Expression and Purification of CFP32 of Mycobacterium Tuberculosis and Its Serodiagnostic Analysis].

Expression and Clinical Application of Recombinant Fusion Protein CFP10-MPT48-TB8.4 of Mycobacterium Tuberculosts

A New Method of Tuberculosis Infection Diagnosis—Enzyme-Linked Immunospot Assay

Diagnostic Performance of a Novel Mycobacterium Tuberculosis Specific T-Cell Based Assay for Tuberculosis

Evaluation of enzyme-linked immunospot assay detecting Mycobacterium tuberculosis specific T cell responses in patients with pulmonary tuberculosis

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Investigation of the Latent Mycobacterium Tuberculosis Infections in Different Populations in Shenzhen Area Using a Tuberculosis Antigen-Specific IFN-γ Elispot Assay.

Exploring the Usage of ELISPOT As a Diagnostic Method for TB

Enhanced Serodiagnostic Utility of Novel Mycobacterium Tuberculosis Polyproteins

Specific T-cell Responses to CFP10, an Secreted Antigens of Mycobacterium Tuberculosis Protein, in Chinese HIV Positive Individuals

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial

ELISpot in the diagnosis of tuberculous meningitis